Signaling pathways
-
BA8241 BI-4916Summary: BI-4916 is a precursor of BI-4924. - BA8242 BI-4924Summary: BI-4924 is a lipophilic
- BA8243 PKUMDL-WQ-2101Summary: PKUMDL-WQ-2101 is a non-NAD competitive variant of phosphoglycerate dehydrogenase inhibitor.
- BA8244 PHGDH-IN-3Summary: PHGDH-IN-3 is a phosphoglycerate dehydrogenase inhibitor with oral activity.
- BA8245 PKUMDL-WQ-2201Summary: PKUMDL-WQ-2201 is a non-NAD+ competitive mutation inhibitor (=35.7 μM).
- BA8247 DPTIPSummary: DPTIP is a potent, neutral sphingomyelinase (exosome inhibitor) that crosses the blood-brain barrier.
- BA8248 LFHP-1cSummary: LFHP-1c is an inhibitor with neuroprotective activity in ischemic stroke.
- BA8249 CAY10650Summary: CAY10650 is a potent inhibitor of cytoplasmic phospholipase A2α.
- BA8250 LEI-401Summary: LEI-401 is a first-of-its-kind, selective, blood-brain barrier-crossing inhibitor of (N-acylphosphoethanolamine phospholipase D).
- BA8251 CCT129957Summary: CCT129957 is an indole derivative.